Items where authors include "Olavarria, E."

Article

Ghorashian, S. orcid.org/0000-0002-1555-2946, Sanderson, R. orcid.org/0000-0003-4915-2833, Lee, J. et al. (6 more authors) (2026) Position statement from the British Society of Blood and Marrow Transplantation and Cellular Therapy on insertional oncogenesis in gene‐engineered advanced cell therapy products for treatment of haematological disorders. British Journal of Haematology, 208 (2). pp. 776-778. ISSN 0007-1048

Clark, A. orcid.org/0000-0001-9593-9528, Clouston, H., Rao, K. et al. (10 more authors) (2025) UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation (HSCT): best practice consensus guidelines from the British Society for Blood and Marrow Transplant and Cellular Therapies (BSBMTCT), NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group, UK Cancer Genetics Group (UKCGG) and the UK National External Quality Assessment Service for Leucocyte Immunophenotyping (UK NEQAS LI). Br J Haematol, 207 (5). pp. 1802-1814. ISSN 0007-1048

Kazmi, M. orcid.org/0000-0002-6863-6297, Muraro, P.A., Mehra, V. orcid.org/0000-0001-6572-0971 et al. (16 more authors) (2025) Autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK: a 20-year retrospective analysis of activity and haematological outcomes from the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT). British Journal of Haematology, 207 (3). pp. 977-991. ISSN 0007-1048

Mayor, N.P., Szydlo, R.M., Sheikh, Y. et al. (9 more authors) (2024) The impact of patient ethnicity on haematopoietic cell transplantation outcome: a retrospective cohort study on the UK experience. The Lancet Haematology, 11 (12). E916-E926. ISSN 2352-3026

Conference abstract

Young, R., Pearce, R., Wilson, M. et al. (14 more authors) (2025) 1046P Outcome of UK germ cell patients treated with high dose chemotherapy: A 20-year review of the BSBMTCT registry. [Conference abstract]